Walgreens, Kroger Sue Pfizer For Delay Of Generic Lipitor

Law360, New York (July 6, 2012, 3:14 PM EDT) -- Walgreen Co., The Kroger Co. and three other retailers on Thursday lodged the latest suit to accuse Pfizer Inc. of using bogus patent applications and a conspiracy with Ranbaxy Inc. to delay generic versions of the blockbuster cholesterol treatment Lipitor.

Walgreens and Kroger — the nation's largest pharmacy and supermarket chains, respectively — said Pfizer and its subsidiaries used a wide range of anti-competitive tactics to extend their exclusive hold on the mega-grossing cholesterol drug by 20 months, at the expense of both retailers and consumers....
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.